Key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias - 2005

被引:5
作者
Ito, MK
Cheung, RJ
Gupta, EK
Birtcher, KK
Chong, PH
Bianco, TM
Bleske, BE
机构
[1] Oregon State Univ, Coll Pharm, Portland Program, Oregon Hlth Sci Univ, Portland, OR 97239 USA
[2] Loma Linda Univ, Sch Pharm, Loma Linda, CA 92350 USA
[3] Western Univ, Sch Pharm, Pamona, CA USA
[4] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[5] John H Stroger Jr Hosp, Dept Pharm, Chicago, IL USA
[6] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
来源
PHARMACOTHERAPY | 2006年 / 26卷 / 07期
关键词
dyslipidemia; cholesterol; guidelines; hypercholesterolemia; hypertriglyceridemia; coronary heart disease;
D O I
10.1592/phco.26.7.939
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Hypercholesterolemia is a major risk factor for development of coronary heart disease. Proper diagnosis and adequate treatment are vital to reducing morbidity and mortality associated with elevated serum lipid levels. The amount of literature in this area is overwhelming. To aid practitioners and educators in organizing this large body of information, we compiled key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias. Research articles were chosen based on the significance of findings, relevance to practice, quality of research, and timeliness; recent articles were given priority over earlier ones unless they demonstrated groundbreaking findings.
引用
收藏
页码:939 / 1010
页数:72
相关论文
共 3 条
[1]
Genest J., Lipoprotein disorders and cardiovascular risk, J Inherit Metab Dis, 26, pp. 267-287, (2003)
[2]
Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report, Circulation, 106, pp. 3143-3421, (2002)
[3]
Pearson T.A., Laurora I., Chu H., Et al., The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals, Arch Intern Med, 160, pp. 459-467, (2000)